therapeutic resist remain principal problem act myeloid leukemia aml use area receive oper characters curve au quantify bail predict individual patient depot perfect predict coin flip use data newly diagnose given induce therapy intent standard regimen mrcncri hoon smog md anderson cancer center studi age perform status white blood cell count secondary disease cytogenet risk fltitdnpm mutant indeed assoc failure achieve complete remains despite early death primary refractory howe bootstrapcorrect cultivar model predict outcome india fair predict remove fluid num inform slightly decrease define short relapsefre survive rf even difficult forecast base routine avail retreat cover provide rational continue random new therapy support examine gene posttreat optic 